PLATELET GLYCOPROTEIN IIB/IIIA MONOCLONAL-ANTIBODY (C7E3) REDUCES DISTAL EMBOLIZATION DURING PERCUTANEOUS INTERVENTION OF SAPHENOUS-VEIN GRAFTS

被引：0
|
作者：
CHALLAPALLI, RM [1 ]
EISENBERG, MJ [1 ]
SIGMON, K [1 ]
LEMBERGER, J [1 ]
机构：
[1] CLEVELAND CLIN,CLEVELAND,OH 44106
来源：
CIRCULATION | 1995年 / 92卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2908 / 2908
页数：1
相关论文
共 50 条
  • [21] Sudden onset of EDTA-dependent pseudothrombocytopenia after therapy with the glycoprotein IIb/IIIa antagonist c7E3 Fab
    H. Stiegler
    Y. Fischer
    S. Steiner
    B. E. Strauer
    H. Reinauer
    Annals of Hematology, 2000, 79 : 161 - 164
  • [22] Sudden onset of EDTA-dependent pseudothrombocytopenia after therapy with the glycoprotein IIb/IIIa antagonist c7E3 Fab
    Stiegler, H
    Fischer, Y
    Steiner, S
    Strauer, BE
    Reinauer, H
    ANNALS OF HEMATOLOGY, 2000, 79 (03) : 161 - 164
  • [23] Effects of the glycoprotein IIb/IIIa receptor antagonist c7E3 Fab and anticoagulants on platelet aggregation and thrombin potential under high coagulant challenge in vitro
    Koestenberger, M
    Gallistl, S
    Cvirn, G
    Roschitz, B
    Muntean, W
    BLOOD COAGULATION & FIBRINOLYSIS, 2000, 11 (05) : 425 - 432
  • [24] Evidence for prevention of death and myocardial infarction with platelet membrane glycoprotein IIb/IIIa receptor blockade by abciximab (c7E3 Fab) among patients with unstable angina undergoing percutaneous coronary revascularization
    Lincoff, AM
    Califf, RM
    Anderson, KM
    Weisman, HF
    Aguirre, FV
    Kleiman, NS
    Harrington, RA
    Topol, EJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 30 (01) : 149 - 156
  • [25] Is early loss of minimal luminal diameter after successful PTCA prevented by c7E3 IIb/IIIa antiplatelet antibody?
    Leon, MN
    Gold, HK
    Mahdi, NA
    Harrell, L
    Rodriguez, A
    Palacios, IF
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 55A - 55A
  • [26] SHEAR-INDUCED PLATELET-AGGREGATION IS INHIBITED BY IN-VIVO INFUSION OF AN ANTI-GLYCOPROTEIN IIB/IIIA ANTIBODY FRAGMENT, C7E3 FAB, IN PATIENTS UNDERGOING CORONARY ANGIOPLASTY
    KONSTANTOPOULOS, K
    KAMAT, SG
    SCHAFER, AI
    BANEZ, EI
    JORDAN, R
    KLEIMAN, NS
    HELLUMS, JD
    CIRCULATION, 1995, 91 (05) : 1427 - 1431
  • [27] THE EFFECT OF THROMBIN INHIBITION AND ANTIPLATELET MEMBRANE GLYCOPROTEIN-IIB/IIIA MONOCLONAL ANTIBODY-7E3 ON PLATELET DEPOSITION IN A NEW EXVIVO ANGIOPLASTY MODEL
    KAPLAN, AV
    LEUNG, LLK
    LEUNG, WH
    FISCHELL, TA
    ARTERIOSCLEROSIS, 1990, 10 (05): : A945 - A945
  • [28] CHIMERIZATION OF MONOCLONAL-ANTIBODY 7E3 PRESERVES THE GPIIB/IIIA RECEPTOR BLOCKADE AND PLATELET FUNCTIONAL INHIBITION OF MURINE 7E3
    BHATTACHARYA, S
    WEISMAN, HF
    MORRIS, KG
    MILLER, MJ
    JORDAN, RE
    SENIOR, R
    SANE, DC
    MACKIE, I
    MACHIN, S
    LAHIRI, A
    CLINICAL RESEARCH, 1991, 39 (02): : A196 - A196
  • [29] MONOCLONAL-ANTIBODY TO IIB-IIIA RECEPTOR (M7E3) IS HIGHLY EFFECTIVE IN INHIBITING ACUTE STENT THROMBOSIS
    MAKKAR, RR
    EIGLER, NL
    NAKAMURA, M
    LITVACK, FI
    BADIMON, L
    JORDAN, R
    BRAMFITT, J
    KAUL, S
    CIRCULATION, 1995, 92 (08) : 3291 - 3291
  • [30] Monoclonal antibody fragment against glycoprotein IIbIIIa, c7E3 Fab, prevents shear stress induced platelet shape change in vitro and in vivo
    Perlemuter, K
    Ajzenberg, N
    Masse, JM
    DuboisRande, JL
    Dupouy, P
    Baruch, D
    Castaigne, A
    Cramer, EM
    CIRCULATION, 1997, 96 (08) : 15 - 15
12345